Reappraisal of parenteral antimicrobial therapy for nontyphoidal Salmonella enteric infection in children

Clinical Microbiology and Infection

Volumn 17, Issue 2, 2011, Pages 300-305

  Tsai, M H ^a,b   Huang, Y C ^b   Lin, T Y ^b   Huang, Y L ^b   Kuo, C C ^b   Chiu, C H ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Antimicrobial therapy; Children; Complication; Enteric infection; Nontyphoidal Salmonella

Indexed keywords

AMPICILLIN; C REACTIVE PROTEIN; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; FLOMOXEF; GENTAMICIN; IMIPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE APPENDICITIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; FECES CULTURE; FEMALE; FEVER; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IN VITRO STUDY; INFANT; INTESTINE MUCOSA; INTESTINE PERFORATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SALMONELLA CHOLERAESUIS; SALMONELLA ENTERITIDIS; SALMONELLOSIS; TOXIC MEGACOLON;

SALMONELLA;

EID: 78751625839     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03230.x     Document Type: Article

References (28)

1. Cohen ML, Tauxe RV. Drug-resistant Salmonella in the United States: an epidemiology perspective. Science 1986; 234: 964-969.
2. Mead PS, Slutsker L, Dietz V et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5: 607-625.
3. Tauxe RV. Emerging foodborne disease: an evolving public health challenge. Emerg Infect Dis 1997; 3: 425-434.
4. Chiu CH, Lin TY, Ou JT. Predictors for extraintestinal infection of non-typhoid Salmonella in patients without AIDS. Int J Clin Pract 1999; 53: 161-164.
5. Torrey S, Fleisher G, Jaffe D. Incidence of Salmonella bacteremia in infants with Salmonella gastroenteritis. J Pediatr 1986; 108: 718-721.
6. Sirinavin S, Jayanetra P, Thakkistian A. Clinical and prognostic categorization of extraintestinal nontyphoidal Salmonella infections in infants and children. Clin Infect Dis 1999; 29: 1151-1156.
7. Aserkoff B, Bennett JV. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N Engl J Med 1969; 281: 636-640.
8. Chiu CH, Lin TY, Ou JT. A clinical trial comparing oral azithromycin, cefixime and no antibiotics in the treatment of acute uncomplicated Salmonella enterocolitis in children. J Paediatr Child Health 1999; 35: 372-374.
9. American Academy of Pediatrics. Salmonella infections. In: Pickering LK, ed. 2009 Red book: report of the committee on infectious diseases, 28th edn. Elk Grove Village, IL: American Academy of Pediatrics, 2009; 584-589.
10. Wistrom J, Jertborn M, Ekwall E et al. Empiric treatment of acute diarrheal disease with norfloxacin: a randomized placebo controlled study. Swedish Study Group. Ann Intern Med 1992; 117: 202-208.
11. Su LH, Chiu CH. Salmonella: clinical importance and evolution of nomenclature. Chang Gung Med J 2007; 30: 210-218.
12. Su LH, Chiu CH, Chu C, Ou JT. Antimicrobial resistance in nontyphoidal Salmonella serotypes: a global challenge. Clin Infect Dis 2004; 39: 546-551.
13. Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increased ceftriaxone resistance in Salmonella isolates: from a university hospital in Taiwan. J Antimicrob Chemother 2005; 55: 846-852.
14. Cherubin CE, Eng RH, Smith SM, Goldstein EJ. Cephalosporin therapy for salmonellosis. Arch Intern Med 1986; 146: 2149-2152.
15. Bryan JP, Scheld WM. Therapy of experimental meningitis due to Salmonella enteritidis. Antimicrob Agents Chemother 1992; 36: 949-954.
16. Ti T, Monteiro EH, Lam S, Lee H. Ceftriaxone therapy in bacteremic typhoid fever. Antimicrob Agents Chemother 1985; 28: 540-543.
17. Chiu CH, Wu TL, Su LH et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N Engl J Med 2002; 346: 413-419.
18. Farmer JJ. Enterobacteriaceae: introduction and identification. In: Murray PR, Baron EJ, Pfaller MA, eds, Manual of clinical microbiology, 6th edn. Washington, DC: American Society of Microbiology, 1995; 438-449.
19. Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing. Document M100-S17. Wayne, PA: CLSI, 2007.
20. Huang IF, Wagener MM, Hsieh KS et al. Nontyphoid salmonellosis in Taiwan children: clinical manifestations, outcomes and antibiotic resistance. J Pediatr Gastroenterol Nutr 2004; 38: 518-523.
21. Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 2002; 8: 490-495.
22. Sirinavin S, Garner P. Antibiotics for treating salmonella gut infections. Cochrane Database Syst Rev 2000; 2: CD001167.
23. Su LH, Chiu CH, Kuo AJ et al. Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983-1999. Epidemiol Infect 2001; 127: 207-213.
24. Nelson JD, Kusmiesz H, Jackson LH, Woodman E. Treatment of Salmonella gastroenterocolitis with ampicillin, amoxicillin, or placebo. Pediatrics 1980; 65: 1125-1130.
25. Garcia-del Portillo F. Salmonella intracellular proliferation: where, when and how? Microbes Infect 2001; 3: 1305-1311.
26. Lin TY, Chiu CH, Lin PY, Wang MH, Su LH, Lin TY. Short-term ceftriaxone therapy for treatment of severe non-typhoidal Salmonella enterocolitis. Acta Paediatr 2003; 92: 537-540.
27. Anton PA, Kemp JA, Butler T, Jacobs MR. Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection. Antimicrob Agents Chemother 1982; 22: 312-315.
28. Chiu CH, Lin TY, Ou JT. In vitro evaluation of intracellular activity of antibiotics against nontyphoid Salmonella. Int J Antimicrob Agents 1999; 11: 47-52.